302964-06-3

Basic information

• Product Name: Carbamic acid, [5-[[(2-chloro-6-methylphenyl)amino]carbonyl]-2-thiazolyl]-, 1,1-dimethylethyl ester
• CAS NO: 302964-06-3
• Molecular Formula: C16H18ClN3O3S
• Molecular Weight: 367.856
• Mol File: 302964-06-3.mol
• Article Data: 15

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [5-[[(2-chloro-6-methylphenyl)amino]carbonyl]-2-thiazolyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [5-[[(2-chloro-6-methylphenyl)amino]carbonyl]-2-thiazolyl]-, 1,1-dimethylethyl ester(302964-06-3)
• EPA Substance Registry System: Carbamic acid, [5-[[(2-chloro-6-methylphenyl)amino]carbonyl]-2-thiazolyl]-, 1,1-dimethylethyl ester(302964-06-3)

Safety Data

• Hazardous Substances Data: 302964-06-3(Hazardous Substances Data)

Upstream product

• 79-37-8 oxalyl dichloride 
• 1101105-53-6 2-tert-butoxycarbonyloxyamino-thiazole-5-carboxylic acid chloride 
• 87-63-8 2-chloro-6-methylaniline 
• 302964-02-9 2-[(tert-butoxycarbonyl)amino]-1,3-thiazole-5-carboxylic acid 
• 302964-01-8 ethyl 2-[(tert-butoxycarbonyl)amino]-1.3-thiazole-5-carboxylate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 302964-20-1 2-tert-butoxycarbonylamino-1,3-thiazole-5-carboxylic acid chloride 

Downstream Products

• 302964-07-4 2-bromo-N-(2-chloro-6-methylphenyl)-1,3-thiazole-5-carboxamide 
• 302961-18-8 N-(2-chloro-6-methylphenyl)-2-[(2,6-dimethyl-4-pyrimidinyl)amino]-5-thiazolecarboxamide 

Relevant articles and documents

SUBSTITUTED ARYLUREA COMPOUNDS FOR INDUCING APOPTOSIS AND COMPOSITION FOR ANTICANCER COMPRISING THE SAME

The present invention relates to a substituted arylurea compound inducing apoptosis and an anticancer composition comprising the same. The present invention relates to a novel compound capable of preventing, treating and alleviating cancer diseases such as prostate cancer, breast cancer, lung cancer, colorectal cancer, and skin cancer by inhibiting apoptosis of cancer cells and inhibiting proliferation of cancer cells.

Scalable and impurity-free process for dasatinib: Src and BCR-Abl inhibitor

An efficient, telescopic, impurity-free and scalable process for Bcr-Abl and Src family tyrosine kinase inhibitor for synthesis of Dasatinib with high yield and purity is described.

Dasatinib derivative with anti-tumor activity and application thereof

The invention belongs to the technical field of medicine chemistry and particularly relates to a dasatinib derivative with anti-tumor activity and application thereof. The dasatinib derivative provided by the invention has a very good inhibition effect on tyrosine kinase and has a very good application prospect for developing in the anti-tumor aspect.